Zahraa Chorghay, PhD

Zahraa Chorghay, PhD, specialized in neuroscience during her undergraduate (University of Toronto) and doctoral studies (McGill University). She continues to explore her passion for neuroscience and for making science accessible and inclusive.

Home
Author
Zahraa Chorghay, PhD

Articles by Zahraa Chorghay, PhD

The consortium includes data from more than 35,000 biofluid samples, leading to approximately 250 million unique protein measurements.

Global Neurodegeneration Proteomics Atlas Reveals Key Disease Signatures

Zahraa Chorghay, PhD

A global harmonized proteomics dataset of Alzheimer’s, Parkinson’s, and FTD uncovers disease signatures to accelerate diagnostics and therapeutic discovery

Despite the alarming statistics, many sepsis-related deaths are preventable through rapid diagnosis and treatment.

Challenges and Advances in Sepsis Detection

Zahraa Chorghay, PhD

FDA-approved tests like Intellisep and TriVerity™ demonstrate potential for early sepsis diagnosis

In 2025, many of the most promising trials center innovations in precision diagnostics, genetic testing, and computational modeling, especially in high-need areas like rare diseases and oncology.

Top 5 Clinical Trials Shaping Medicine in 2025

Zahraa Chorghay, PhD

From precision oncology to gene editing, these standout trials could redefine how we diagnose and treat rare diseases and cancer

Illustration of clinical laboratory professionals wearing lab coats with DNA molecules in the background to represent Sanger sequencing

Sanger Sequencing for Specific and Small-Scale DNA Testing

Zahraa Chorghay, PhD

Cost, time, and labor considerations still make the Sanger method a better choice amidst new sequencing technologies

One in a Million: A Nationwide Diagnostics Strategy for Ultrarare Diseases

Zahraa Chorghay, PhD

Leveraging integrated healthcare frameworks can significantly reduce diagnostic delays

Illustration of a girl holding her abdomen in pain, with a speech bubble from her abdomen showing a sad (diseased) liver.

AAV2 Virus Thought to Underlie 2022 Hepatitis Outbreak in Children

Zahraa Chorghay, PhD

Researchers use metagenomics and targeted sequencing to identify non-A–E hepatitis cases in the US and Scotland/UK

Illustration of a clinical lab professional scientist in the lab and interacting with a virtual user interface targeting a DNA strand with probes for real-time PCR for pathogen detection.

Why Are Real-Time PCR Panels Gaining Popularity for Molecular Testing?

Zahraa Chorghay, PhD

Accurate, versatile, fast, and affordable testing for infectious diseases, oncology, and pharmacogenomics

Different coloured points joined by lines against a colourful background, representing the need for algorithms to make sense of complex data.

Can Clinical Flow Cytometry Gating Analysis Be Automated?

Zahraa Chorghay, PhD

Unsupervised and supervised algorithms can improve the efficiency and reproducibility of flow cytometric analysis

Lab personnel, seated near a microscope, examines immunohistochemistry slide with her gloved hand, prior to placing the cancer specimen under the microscope.

Can Immunohistochemistry Assays Be Standardized for Cancer Detection?

Zahraa Chorghay, PhD

New synthetic immunohistochemistry reference standards could enable semiquantitative tumor analysis for emerging immunotherapies

Photograph of a raccoon in green sunglasses showing a rock gesture, representing the pet raccoon that was affected by contaminated aromatherapy spray leading to a melioidosis outbreak.

What Do Aromatherapy and a Pet Raccoon Have to Do with Melioidosis?

Zahraa Chorghay, PhD

Melioidosis outbreak across southern US states attributed to contaminated imported aromatherapy spray

Photograph of a vial labelled monoclonal antibody held in someone’s palms, represent lecanemab administration.

Alzheimer’s Drug Slows Mental Decline but at What Cost?

Zahraa Chorghay, PhD

Clinical trial for lecanemab shows moderate cognitive benefit but also potential safety risks

Illustration of a drop of blood held in palms facing upward with logos of money and technology in the background, representing the blood-testing technology of Theranos situated in the well-financed biotechnology sector.

Theranos CEO Elizabeth Holmes Sentenced to 11 Years in Prison

Zahraa Chorghay, PhD

Holmes found guilty of defrauding investors, with implications for the tech industry

Illustration of a bag of blood held in someone’s palms being transfused into another person, with the tube forming a heart shape, representing the donor-recipient relationship for blood transfusions.

Lab-Grown Blood Given to Humans in First Trial

Zahraa Chorghay, PhD

The RESTORE clinical trial in the UK will assess the viability of manufactured blood

Photograph of baby with an inhalation mask as they are being treated for respiratory syncytial virus (RSV) at a hospital.

RSV Cases Soar in Pediatric Populations

Zahraa Chorghay, PhD

Public health recommendations and a new vaccine could help keep babies safe

3D illustration of a large helicase enzyme interacting with the DNA double helix as part of the amplification process.

Will Thermocyclers Soon Be Obsolete?

Zahraa Chorghay, PhD

A new engineered DNA helicase bypasses the need for a thermocycler